
Bath & Body Works (BBWI) has introduced Essentials, a sensitive-skin body care franchise built around hypoallergenic formulas, new body wash and lotion formats, and coordinating Eau de Parfum.
The line features three spa-inspired scents, dermatologist approval and routine-based pricing tiers. This gives investors a fresh product launch to watch as they assess how the stock trades from here.
Set against that product launch, Bath & Body Works shares have been under pressure, with the share price down 15.8% over the past month and 30% over the past three months, while the 1-year total shareholder return has declined 35.2% and the 5-year total shareholder return is down 71%.
Scan how Bath & Body Works compares to other retailers under pressure by reviewing our curated 32 high quality undervalued stocks that may offer stronger quality at discounted prices.
Bath & Body Works now trades at a steep discount to both analyst targets and some intrinsic value estimates after that sharp slide. Is the gap signaling opportunity, or is it simply matching the risk the market sees?
Bath & Body Works last closed at $16.19, while the most followed narrative pegs fair value at $28.73 using a 9.0% discount rate and sees a sizeable gap between price and fundamentals.
BBW is set to renegotiate leases over time. Favorably updated rent agreements, new off-mall locations, and productivity gains from the White Barn format conversion could help boost profits.
See why 24 investors see Bath & Body Works as 44% undervalued.
Result: Fair Value of $28.73 (UNDERVALUED)
Still, Bath & Body Works faces real swing factors if mall traffic weakens further or if fast changing fragrance trends force heavier discounting to clear shelves.
Find out about the key risks to this Bath & Body Works narrative.
Mixed messages on Bath & Body Works so far. If you think the story is moving faster than the headlines, weigh the full picture by checking 2 key rewards and 3 important warning signs.
If Bath & Body Works has your attention, do not stop here. Use targeted screeners to surface fresh opportunities before the crowd gets to them.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com